Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Bronchodilatory Effect of Higenamine As Antiallergic Asthma Treatment Publisher Pubmed



Du J1 ; Mehrabi Nasab E2 ; Athari SS3 ; Qian L4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Hospital Infection Management, The Fourth People's Hospital of Chengdu, Sichuan Province, Chengdu, China
  2. 2. Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  4. 4. Department of General Surgery, Yancheng No.1 Peoples's Hospital, Yancheng, Jiangsu Province, China

Source: Journal of Investigative Medicine Published:2022


Abstract

Asthma is a complex airway disease that affects more than 350 million humans worldwide. Allergic asthma symptoms are induced by Th2 immune response with the release of cytokines and allegro-inflammatory mediators that amplify the inflammatory response, airway hyper-responsiveness (AHR) and hyperproduction of mucus. Higenamine, as a chemical compound, is a β 2 adrenoreceptor agonist and can be used as bronchodilator in allergic asthma. BALB/c mice were allocated in four groups and then allergic asthma was induced in three groups. One of the asthmatic groups was treated with albuterol and other one was treated with higenamine. At least, methacholine challenge to determine the AHR, measurement of cytokines, total immunoglobulin E (IgE), LTB4 and LTC4 levels, evaluation of gene expression of Muc5ac, Muc5b, Agr2 and Arg1, and histopathological study were done. Higenamine treatment reduced AHR, interleukin (IL)-4, IL-13 levels, mRNA expression of MUC5ac, MUC5b, Arg1 and Agr2, goblet cell hyperplasia and mucus hypersecretion. Higenamine had no significant effect on IL-5, interferon-γ(INF- 3), IgE, LTB4, LTC4 levels and eosinophilic inflammation in lung tissue. Higenamine treatment controls asthma acute attack and breathlessness and can be used as asthma treatment with control of AHR and decrease of airflow obstruction and mucus hypersecretion and had allegro-immune-regulatory effect. But higenamine treatment had no notable effect on the inflammation and inflammatory factors. © 2022 Journal of Investigative Medicine. All rights reserved.
Related Docs
1. Pulmonary Delivery of Levamisole Nanoparticles As an Immunomodulator Affecting Th and a Potential Adam10 Inhibitor to Ameliorate Severe Allergic Asthma, ACS Biomaterials Science and Engineering (2022)
2. Study Effect of Probiotics and Prebiotics on Treatment of Ova-Lps-Induced of Allergic Asthma Inflammation and Pneumonia by Regulating the Tlr4/Nf-Kb Signaling Pathway, Journal of Translational Medicine (2022)
3. Mitochondria Signaling Pathways in Allergic Asthma, Journal of Investigative Medicine (2022)
4. The Effects of Combined Therapeutic Protocol on Allergic Rhinitis Symptoms and Molecular Determinants, Iranian Journal of Allergy# Asthma and Immunology (2022)
Experts (# of related papers)
Mohammad Gharagozlou (1)